Investing Profile

Klaus Veitinger

InvestorVC
Venture Partner at OrbiMed
orbimed.comNew York, New York
Photo of Klaus Veitinger, Venture Partner at OrbiMed

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
OrbiMed Network
32 CONNECTIONS
cb
OrbiMed Venture Partner
$1M - $75.0M
$4.0M
9
$18B
CompanyStageDateRound SizeTotal Raised
Sparrow Pharmaceuticals
Series BSep 2025$95M
Series UnknownApr 2024$10M
Series AMay 2021$50M
$160M
Co-investors: Zach Scheiner (RA Capital Management), Nanna Luneborg (Forbion), Jonathan Root (U.S. Venture Partners (USVP))
Alpheus Medical
Series BMay 2025$52M
Series ANov 2022$14M
Series ANov 2021$16M
$82M
Co-investors: Imran Eba (Action Potential Venture Capital), Conrad Wang (SLR Capital Partners), Daniel Coley (Cofounders Capital)
Neurogastrx
Series BAug 2021$60M
Series AJan 2018$45M
$110M
Co-investors: Aaron Royston (venBio), David Allison (Westlake Village BioPartners)
Promentis Pharmaceuticals
Series CMar 2017$26M
$26M
Vice Chairman of the Board AnorMEDPresent
Board Member Synageva BioPharma Corp.Present
Vice Chairman of the Board HotmailPresent
Board Member Intercept PharmaceuticalsPresent
Chairman of the Board Tricida, Inc.Present
Board Member scPharmaceuticalsPresent
Chairman of the Board Neurogastrx, Inc.Present
Board Member ACGTPresent
Executive Chairman AlpheusPresent
Chairman of the Board Sparrow Pharmaceuticals, Inc.Present
Investor Representative HotmailPresent
Board Member Cure Rare DiseasePresent
Executive Chairman HotmailPresent
CEO HotmailPresent
Venture Partner OrbiMedPresent